Enfuego Therapeutics, Inc.
Pittsboro, NC
- UEI
- N4XYELPNM224
- CAGE
- 88ZM3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 37 Linda Lee Cir, Pittsboro, NC 27312, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Ligand-directed kras G12V mutant-specific therapeutics | National Cancer Institute (NIH) | $4,503,015 | |
| Development of eftx-001 to target kras mutations in cancer | National Cancer Institute (NIH) | $224,995 |
Quick answers
Is Enfuego Therapeutics, Inc. registered in SAM.gov?
Yes. Enfuego Therapeutics, Inc.'s SAM.gov registration is active through July 8, 2027.
What is Enfuego Therapeutics, Inc.'s most recent federal award?
Enfuego Therapeutics, Inc.'s most recent federal grant award is Ligand-directed kras G12V mutant-specific therapeutics (R44CA284932), from National Cancer Institute (NIH), on July 5, 2023.
On GovTribe
See Enfuego Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors